1. Editorial: finding the ideal prokinetic for gastroparesis – we are not there yet;Mahadeva S;Aliment Pharmacol Ther,2021
2. Randomised study: effects of the 5 HT4 receptor agonist felcisetrag versus placebo on gut transit in patients with gastroparesis;Chedid V;Aliment Pharmacol Ther,2021
3. Randomised clinical trial: safety, pharmacokinetics and pharmacodynamics of trazpiroben (TAK‐906), a dopamine D2/D3 receptor antagonist, in patients with gastroparesis;Kuo B;Aliment Pharmacol Ther,2021
4. Functional dyspepsia and gastroparesis in tertiary care are interchangeable syndromes with common clinical and pathologic features;Pasricha PJ;Gastroenterology,2021
5. Gastric motor dysfunction in patients with functional gastroduodenal symptoms;Park SY;Am J Gastroenterol,2017